Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Talk outline
3. Variceal bleeding
4. Varices increase in diameter progressively
5. Beta blocker prevention of first variceal hemorrhage
6. Variceal hemorrhage
7. Variceal bleeding pearls
8. Ascites
9. Ascites management
10. Hepatorenal syndrome
11. Hepatorenal survival
12. HRS treatment
13. Vasoconstrictors and HRS
14. West Haven classification of HE
15. Precipitants of HE
16. Rifaximin vs. nonabsorbable disaccharides
17. Hepatopulmonary syndrome
18. Hepatopulmonary syndrome survival rate
19. Transplantation outcome in HPS patients
20. Portopulmonary hypertension
21. PPHTN: liver transplantation
22. Evaluation/preparation for liver transplantation (1)
23. Evaluation/preparation for liver transplantation (2)
24. Alcohol and transplantation
25. Hepatitis B
26. Hepatitis C treatment prior to transplantation
27. NASH/metabolic syndrome
28. Liver transplantation for HCC: Milan criteria
29. UCSF criteria for HCC
30. Listing criteria for liver transplantation
31. Liver allocation MELD score
32. Mortality risk according to MELD
33. Change to inactive status
34. Medical conditions after liver transplantation
35. Biliary endoscopy
36. Fluoroscopic view of ERCP: anastomotic strictures
37. Fluoroscopic view of ERCP: biliary leaks
38. Biliary casts - endoscopy
39. GI related disorders
40. Inflammatory bowel disease
41. Colon cancer, IBD, PSC and transplantation
42. Annual examinations
43. Vaccination
44. Obesity
45. Bone disease
46. Bone disease recommendations
47. Cardiovascular disease
48. Cardiovascular recommendations
49. Diabetes
50. Patient/graft survival in patients with or W/O DM
51. CRF after solid organ transplantation
52. Renal disease
53. De novo malignancy
54. Long-term causes of death
55. Drug interactions in transplantation medications
56. Future prospects

Topics Covered

• Common complications of end stage cirrhosis including life threatening disorders of variceal bleeding, ascites, hepatorenal syndrome, encephalopathy and hepatopulmonary syndrome
• Preparation for listing for liver transplantation in patients with end stage liver disease includes documentation and absence of alcohol consumption (in alcoholics), reduction of hepatitis B DNA levels (in HBV patients) and aggressive treatment of hepatocellular carcinoma to reduce the risk of recurrent disease
• The most common allocation system for liver transplantation is the model for end stage liver disease
• Post transplantation care of the patient requires diligent annual followup with concentration on common diseases which include: metabolic syndrome (diabetes mellitus, obesity, hypertension, hyperlipidemia), Preventive medicine (vaccination, dental disease), Inflammatory bowel disease, bone disease, and renal dysfunction

Links

Series:

• Gastroenterology and Hepatology

Categories:

• Clinical Practice

Therapeutic Areas:

• Gastroenterology & Nephrology

Talk Citation

McCashland, T.M. (2011, January 5). The management of other aspects of chronic liver disease, including transplantation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved January 21, 2025, from https://doi.org/10.69645/JATB8280.
Export Citation (RIS)

Publication History

• Published on January 5, 2011
• Archived on September 30, 2021

Financial Disclosures

• Prof. Timothy M. McCashland has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.